Volume 10,Issue 1
Fall 2025
Objective: To explore the clinicopathological features, diagnosis, and differential diagnosis of perivascular epithelioid cell tumor (PEComa) of the female genital tract. Methods: The clinical data of four patients with PEComa of the female genital tract were collected, and their histomorphological characteristics were observed. Immunohistochemical staining was performed using the EnVision two-step method, and fluorescence in situ hybridization (FISH) was used to detect TFE3 gene rearrangement. The clinicopathological features were analyzed, and relevant literature was reviewed. Results: None of the four patients were associated with tuberous sclerosis complex, and the lesions were located in the cervix, uterine body, and vaginal stump, respectively. The tumor was mainly composed of epithelioid cells arranged in solid sheets, nests, and bundles. The tumor cells had abundant cytoplasm, which was transparent or eosinophilic and granular. The nuclei showed mild or marked atypia with variable mitotic figures. Tumor necrosis, multinucleated giant cells, and rhabdoid cells were observed in some cases. Immunohistochemistry showed that HMB45, Melan A, MiTF, TFE3, desmin, SMA, and h-caldesmon were positive in three surgical specimens, while S-100 and SOX10 were negative. In one consultation case, HMB45, Melan A, desmin, and SMA were positive, while S-100 was negative. FISH detected no TFE3 gene rearrangement in three cases. Conclusion: PEComa of the female genital tract is prone to misdiagnosis. Combining typical histological, immunohistochemical, and molecular genetic features can help improve diagnostic accuracy.
1. Gadducci A, Zannoni GF, 2020, Perivascular Epithelioid Cell Tumors (PEComa) of the Female Genital Tract: A Challenging Question for Gynecologic Oncologists and Pathologists. Gynecol Oncol Rep, 33: 100603.
2. Dai Y, You Y, Ma X, et al., 2020, Two Cases of Uterine Perivascular Epithelioid Cell Tumor and Literature Review. Chinese Journal of Obstetrics and Gynecology, 55(4): 273–276.
3. WHO Classification of Tumours Editorial Board, 2020, WHO Classification of Tumours: Female Genital Tumours, 5th ed., IARC Press, Lyon, 96–297.
4. WHO Classification of Tumours Editorial Board, 2020, WHO Classification of Tumours: Soft Tissue and Bone Tumours, 5th ed., IARC Press, Lyon, 312–314.
5. Conlon N, Soslow RA, Murali R, 2015, Perivascular Epithelioid Tumours (PEComas) of the Gynecological Tract. J Clin Pathol, 68(6): 418–426.
6. Bennett JA, Oliva E, 2021, Perivascular Epithelioid Cell Tumors (PEComa) of the Gynecologic Tract. Genes Chromosomes Cancer, 60(3): 168–179.
7. Liu CH, Chao WT, Lin SC, et al., 2019, Malignant Perivascular Epithelioid Cell Tumor in the Female Genital Tract: Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Medicine (Baltimore), 98(2): e14072.
8. Bennett JA, Braga AC, Pinto A, et al., 2018, Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors. Am J Surg Pathol, 42(10): 1370–1383.
9. Schoolmeester JK, Howitt BE, Hirsch MS, et al., 2014, Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic Tract: Clinicopathologic and Immunohistochemical Characterization of 16 Cases. Am J Surg Pathol, 38(2): 176–188.
10. Valencia-Guerrero A, Pinto A, Anderson WJ, et al., 2020, PNL2: A Useful Adjunct Biomarker to HMB-45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa). Int JGynecol Pathol, 39(6): 529–536.
11. Schoolmeester JK, Dao LN, Sukov WR, et al., 2015, TFE3 Translocation-Associated Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic Tract: Morphology, Immunophenotype, Differential Diagnosis. Am J Surg Pathol, 39(3): 394–404.
12. Conlon N, Soslow RA, Murali R, 2015, Perivascular Epithelioid Tumours (PEComas) of the Gynaecological Tract. J Clin Pathol, 68(6): 418–426.